Parkinson Disease Treatment Market Share Current and Future Industry Trends, 2020-2025

The MarketWatch News Department was not involved in the creation of this content.

Dec 25, 2020 (AmericaNewsHour) — The global Parkinson’s disease Treatment market was valued at USD 3.94 billion in 2016 and is projected to reach USD 6.65 billion by 2025, growing at a CAGR of 5.99% from 2017 to 2025.

The disorder has currently ongoing research for finding a reliable treatment method and is the topic of interest for major players in the healthcare and medical sector. The market is thus expected to grow at a high CAGR during the forecast period.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report:

Sample Infographics:

Market Dynamics:
1. Market Drivers
1.1 Increasing Geriatric Population
1.2 Growing number of cases of Parkinson’s disorder
1.3 Availability of fund
2. Market Restraints
2.1 Presence of Alternatives

Market Segmentation:
1. By Patient Care Setting:
1.1 Clinics
1.2 Hospitals

2. By Distribution Channel:
2.1 Hospital Pharmacies
2.2 Retailer Pharmacies
2.3 Online Pharmacies

3. By Drug Class:
3.1 Carbidopa/Levodopa
3.2 Dopamine Receptor Agonists
3.3 Mao Inhibitors
3.4 Comt Inhibitors
3.5 Anticholinergics
3.6 Other Drugs

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. GSK
2. Merck
3. Novartis
4. Teva
5. BoehringerIngelheim
6. Impax
7. Abbvie
8. Valeant Pharmaceuticals
9. Lundbeck
10. Sun Pharma
11. Wockhardt
12. Acadia
13. UCB
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Request For Full Report:

Research study on the Parkinson’s disease Treatmentmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research


Phone: +1 313 462 0609

The post Parkinson Disease Treatment Market Share Current and Future Industry Trends, 2020-2025 appeared first on America News Hour.


Is there a problem with this press release? Contact the source provider Comtex at You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.